2D–LC Characterizes Synthetic Oligonucleotides
A new methodology for the characterization of synthetic oligonucleotides has been developed by researchers from the University of Tübingen, Germany.
Photo Credit: stock.adobe.com.nobeastsofierce
A new methodology for the characterization of synthetic oligonucleotides has been developed by researchers from the University of Tübingen, Germany (1).
Synthetic oligonucleotides are a class of synthetic nucleic acids, which are generally 12–30 nucleotides in length. They have gained considerable popularity as a therapeutic tool and are a promising product for the regulation of gene expression. As they are to be used in humans and in clinical trials, their production must lead to high purity products. However, a number of issues can arise during their synthesis, such as deleted or extended base sequences or base modifications, and therefore the purification methods and assays for their quality control must be robust and thorough.
The dominant method currently uses ion-pair reversed-phase chromatography with triethylammonium acetate as an ion-pairing agent because oligonucleotides are poorly retained by common reverse-phase liquid chromatography (LC). However, as this method is hyphenated to mass spectrometry some drawbacks occur, such as ion-suppression in electrospray ionization. As such a methodology with sufficient selectivity and better compatibility for MS detection is desirable.
Towards this end, researchers developed a multiple heart-cutting (MHC) two-dimensional liquid chromatography (2D-LC) method with ultra-violet (UV) and electrospray ionization (ESI) mass spectrometry (MS) detection. The first dimension features a reversed-phase/weak anion-exchange (RP/WAX) stationary phase which provides the selectivity required to separate structurally similar oligonucleotide sequences. The second dimension reversed-phase column desalts via a diverter valve, and the active solvent modulation enables the oligonucleotide peak to be viewed without interference from non-volatile buffer components and ion-pair agents, which allows oligonucleotides to be detected in MS-compatible conditions.
Α α, Β β, Γ γ, Δ δ, Ε ε, Ζ ζ, Η η, Θ θ, Ι ι, Κ κ, Λ λ, Μ μ, Ν ν, Ξ ξ, Ο ο, Π π, Ρ ρ, Σ σ/ς, Τ τ, Υ υ, Φ φ, Χ χ, Ψ ψ, Ω ω
Reference
F. Li et al., J. Chroma. A. 1625, 461338 (2020).
SPME GC-MS–Based Metabolomics to Determine Metabolite Profiles of Coffee
November 14th 2024Using a solid phase microextraction gas chromatography-mass spectrometry (SPME GC-MS)-based metabolomics approach, a recent study by the School of Life Sciences and Technology at Institut Teknologi Bandung (Indonesia) investigated the impact of environmental factors (including temperature, rainfall, and altitude) on volatile metabolite profiles of Robusta green coffee beans from West Java.
RP-HPLC Analysis of Polyphenols and Antioxidants in Dark Chocolate
November 13th 2024A recent study set out to assess the significance of geographical and varietal factors in the content of alkaloids, phenolic compounds, and the antioxidant capacity of chocolate samples. Filtered extracts were analyzed by reversed-phase high-performance liquid chromatography (RP-HPLC) with ultraviolet (UV) and spectrophotometric methods to determine individual phenolics and overall indexes of antioxidant and flavonoid content.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Katelynn Perrault Uptmor Receives the 2025 LCGC Emerging Leader in Chromatography Award
Published: November 13th 2024 | Updated: November 13th 2024November 13, 2024 – LCGC International magazine has named Katelynn A. Perrault Uptmor, Assistant Professor of Chemistry at the College of William & Mary, the recipient of the 2025 Emerging Leader in Chromatography Award. This accolade, which highlights exceptional achievements by early-career scientists, celebrates Perrault Uptmor’s pioneering work in chromatography, particularly in the fields of forensic science, odor analysis, and complex volatile organic compounds (VOCs) research.
